Crohns Disease Clinical Trials

8 recruiting

Frequently Asked Questions

Common questions about Crohns Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting

Prospective Evaluation of the Carbon Footprint and Clinical Utility of IBUS Compared to Colonoscopy and Enterography in UC and CD

Ulcerative Colitis (UC)Crohns Disease
Asian Institute of Gastroenterology, India200 enrolled2 locationsNCT07431983
Recruiting
Phase 3

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohns Disease
Hoffmann-La Roche425 enrolled162 locationsNCT06819891
Recruiting
Phase 3

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

Colitis UlcerativeArthritis, PsoriaticCrohns Disease+1 more
Janssen Research & Development, LLC196 enrolled30 locationsNCT06663332
Recruiting
Phase 3

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohns Disease
Hoffmann-La Roche600 enrolled344 locationsNCT06819878
Recruiting
Not Applicable

VirtuAl Technology to Improve the Management of Perianal Crohn's (VAMP) - PROSPECTIVE

Perianal Crohns Disease
Nottingham University Hospitals NHS Trust30 enrolled1 locationNCT06587646
Recruiting

Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation

PregnancyInflammatory Bowel DiseaseCrohns Disease
Icahn School of Medicine at Mount Sinai46 enrolled1 locationNCT06001450
Recruiting

Magnesium in Gastrointestinal Disease

Ileostomy - StomaBile Acid MalabsorptionColitis Ulcerative+9 more
University of Aarhus120 enrolled1 locationNCT07338565
Recruiting
Phase 1Phase 2

Treatment of Moderate to Severe Refractory Crohn's Disease

Crohns Disease
Tr1X, Inc.39 enrolled13 locationsNCT06721962
Recruiting

Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy

Crohns Disease
Alimentiv Inc.50 enrolled5 locationsNCT06670638
Recruiting
Not Applicable

Preliminary Clinical Study on the Effect of Bacillus Subtilis on the Efficacy of Infliximab in Patients With Crohn's Disease

Mild to Severe Crohns Disease
The Third Xiangya Hospital of Central South University24 enrolled1 locationNCT07123207
Recruiting
Not Applicable

A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Crohn Disease on Advanced Therapies

Crohns Disease
All India Institute of Medical Sciences168 enrolled6 locationsNCT06890637
Recruiting

Development and Validation of a New Paediatric Inflammatory Bowel Disease NUTrition Risk Score (PIBD-NUTS)

Ulcerative Colitis (UC)Inflammatory Bowel Diseases (IBD)Crohns Disease
University of Glasgow2,000 enrolled8 locationsNCT06723418
Recruiting
Not Applicable

Preliminary Clinical Study on the Effect of L-ornithine on the Efficacy of Ustekinumab in Patients With Crohn's Disease

Mild to Severe Crohns Disease
The Third Xiangya Hospital of Central South University50 enrolled1 locationNCT06455267